High-concentration contrast media combined with low tube current for radiation dose reduction in head and neck computed tomography angiography: A prospective study

高浓度造影剂联合低管电流降低头颈部计算机断层扫描血管造影术辐射剂量:一项前瞻性研究

阅读:1

Abstract

High-concentration contrast media (HCCM) is a promising strategy to reduce radiation dose during computed tomography scan. This prospective study aims to assess whether the combination of HCCM and reduced tube current (mAs) can decrease radiation dose without compromising image quality in head and neck computed tomography angiography (CTA). A total of 68 consecutive patients (41 males, 27 females) with a mean age of 60.9 ± 10.9 years, referred for head and neck CTA, were randomly assigned to Group A (iodixanol 320, automatic mAs) and Group B (iomeprol 400, effective mAs reduced by a factor 0.64). CTA were performed with a tube voltage of 100 kV. Radiation dose was assessed by the volume CT dose index (CTDIvol), dose length product, and effective dose. Objective image quality was evaluated based on attenuation, signal-to-noise ratio, and contrast-to-noise ratio. Subjective image quality was rated using a 5-point Likert scale. Group B had significantly lower CTDIvol (4.22 ± 0.54 vs 6.48 ± 0.79 mGy) and dose length product (167.9 ± 24.5 vs 249.1 ± 35.7 mGy*cm) compared to Group A (P <.001). The effective dose in Group B was reduced by 32.5%. CT attenuation values for the internal carotid artery, middle cerebral artery, and aortic arch in Group B were significantly higher than those in Group A (P <.05). No significant differences were found in signal-to-noise ratio or contrast-to-noise ratio. The subjective quality for overall image and main head and neck arteries was significantly higher in Group B compared to Group A. In conclusion, the combination of HCCM and reduced mAs effectively reduces radiation dose without compromising image quality in head and neck CTA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。